Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review.
about
Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data.Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.Investigational serine/threonine kinase inhibitors against prostate cancer metastases.The implications of baseline bone-health assessment at initiation of androgen-deprivation therapy for prostate cancer.Androgen Receptor-CaMKK2 Axis in Prostate Cancer and Bone Microenvironment.
P2860
Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Androgen-deprivation therapy a ...... r patients: a clinical review.
@ast
Androgen-deprivation therapy a ...... r patients: a clinical review.
@en
type
label
Androgen-deprivation therapy a ...... r patients: a clinical review.
@ast
Androgen-deprivation therapy a ...... r patients: a clinical review.
@en
prefLabel
Androgen-deprivation therapy a ...... r patients: a clinical review.
@ast
Androgen-deprivation therapy a ...... r patients: a clinical review.
@en
P2860
P356
P1433
P1476
Androgen-deprivation therapy a ...... r patients: a clinical review.
@en
P2093
P2860
P2888
P356
10.1038/BONEKEY.2015.85
P577
2015-06-24T00:00:00Z